immunity and glutathione Boost Duo Glutathione IV Therapy: What You

Disclosures: Nadeen Habboub: Nothing to Disclose, Despoina Chrysostomou: Nothing to Disclose, Benjamin Challis: Nothing to Disclose, Laura Martinez-Gili: Nothing to Disclose, Julian Marchesi: Nothing to Disclose, Marc Dumas: Nothing to Disclose, Mark Thursz: Durect: Consultant, GSK: Consultant, Resolution Tx: Consultant, Intercept: Consultant, Galecto: Consultant, Durect: Consultant, Benjamin Mullish: Nothing to Disclose, Pinelopi Manousou: Nothing to Disclose 1053 GROWTH HORMONE RESHAPES THE GUT MICROBIAL PROFILE IN INDIVIDUALS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AFTER SIX MONTHS OF TREATMENT Elizabeth Jensen 1 Jonathan Young 2 Mark Chicote 3 Edward List 2 Kathleen Corey 4 John Kopchick 2 Darlene Berryman 2 Laura Dichtel 4 , 1 Cleveland Clinic Foundation

10.1016/j.eurox.2019.100067 262 YangQ.CiebieraM.BarianiM

4), to either mimic non-phosphorylated (S134A) or phosphorylated (S134E) IL-1, had no impact on either IL-1 turnover (Supplementary Fig

This reduces excitotoxicity, and the rate of hair cell loss was also observed to be reduced